Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 129 M258 M203 M187 M210 M192 M 792 M Non-Operating Income, Total -65 M20 M72 M-35 M-6 M-36 M -5 M Interest expense, net of interest capitalized 23 M22 M23 M22 M22 M22 M 89 M Non-Operating Income, excl. Interest Expenses -88 M-2 M49 M-57 M-28 M-58 M -94 M Unusual income/expense —————— — Pretax income 30 M229 M133 M135 M165 M65 M 498 M Equity in earnings 15 M53 M3 M20 M26 M31 M 80 M Taxes 8 M44 M27 M21 M27 M-20 M 55 M Non-controlling/minority interest 4 M9 M3 M9 M19 M-3 M 28 M After tax other income/expense —————— — Net income before discontinued operations 18 M176 M103 M105 M119 M88 M 415 M Discontinued operations —————— — Net income 18 M176 M103 M105 M119 M88 M 415 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 18 M175 M103 M104 M117 M87 M 411 M Basic earnings per share (Basic EPS) 0.413.492.12.22.61.94 8.84 Diluted earnings per share (Diluted EPS) 0.43.442.082.182.561.91 8.73 Average basic shares outstanding 53.3 M50 M48.9 M47.4 M48.1 M44.9 M — Diluted shares outstanding 54.3 M50.7 M49.4 M48 M48.7 M45.4 M — EBITDA 191 M263 M208 M193 M216 M197 M 814 M EBIT 129 M258 M203 M187 M210 M192 M 792 M Cost of revenue 34 M45 M33 M-24 M24 M24 M 57 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 6 M5 M5 M6 M6 M5 M 22 M